InsiderTrades

Form 4 for SOLV Solventum

Accepted 2025-05-15 00:00:00 ET · period of report 2025-05-13 · accession 0001628280-25-025944 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-05-15 2025-05-13 SOLV McMillan Wayde D. CFO M - OptEx $0.00 +9,502 26.4K +56% $0
D 2025-05-15 2025-05-13 SOLV McMillan Wayde D. CFO F - Tax $73.52 -3,918 22.5K -15% -$288.1K
D 2025-05-15 2025-05-13 SOLV McMillan Wayde D. CFO M - OptEx $0.00 -9,502 19.0K -33% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-05-13 M A 9,502 $0.00 26,410 D — —
2 Common Common Stock 2025-05-13 F D 3,918 $73.52 22,492 D — —
3 Derivative Restricted Stock Units 2025-05-13 M D 9,502 $0.00 19,007 D — · — to 2034-05-13 9,502 Common Stock (F1) Each Restricted Stock Unit ("RSU") represents a contingent right to receive 1 share of the issuer's Class A Common Stock upon settlement. (F2) The RSUs shall fully vest in three tranches, with one-third vesting on each of May 13, 2025; May 13, 2026; and May 13, 2027, subject to continued service through the vesting date.